Indeed, recent studies with CD19 CAR-T in ALL and with BCMA-CAR-T in myeloma have shown that the presence of antigen-negative leukemia or myeloma cells leads to outgrowth of these cells and rapid relapse22,23. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.